Literature DB >> 23602765

Dimerization and ubiquitin mediated recruitment of A20, a complex deubiquitinating enzyme.

Timothy T Lu1, Michio Onizawa, Gianna E Hammer, Emre E Turer, Qian Yin, Ermelinda Damko, Alexander Agelidis, Nataliya Shifrin, Rommel Advincula, Julio Barrera, Barbara A Malynn, Hao Wu, Averil Ma.   

Abstract

A20 is an anti-inflammatory protein linked to multiple human autoimmune diseases and lymphomas. A20 possesses a deubiquitinating motif and a zinc finger, ZF4, that binds ubiquitin and supports its E3 ubiquitin ligase activity. To understand how these activities mediate A20's physiological functions, we generated two lines of gene-targeted mice, abrogating either A20's deubiquitinating activity (Tnfaip3(OTU) mice) or A20's ZF4 (Tnfaip3(ZF4) mice). Both Tnfaip3(OTU) and Tnfaip3(ZF4) mice exhibited increased responses to TNF and sensitivity to colitis. A20's C103 deubiquitinating motif restricted both K48- and K63-linked ubiquitination of receptor interacting protein 1 (RIP1). A20's ZF4 was required for recruiting A20 to ubiquitinated RIP1. A20(OTU) proteins and A20(ZF4) proteins complemented each other to regulate RIP1 ubiquitination and NFκB signaling normally in compound mutant Tnfaip3(OTU/ZF4) cells. This complementation involved homodimerization of A20 proteins, and we have defined an extensive dimerization interface in A20. These studies reveal how A20 proteins collaborate to restrict TNF signaling.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23602765      PMCID: PMC3665706          DOI: 10.1016/j.immuni.2013.03.008

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  45 in total

Review 1.  Nonproteolytic functions of ubiquitin in cell signaling.

Authors:  Zhijian J Chen; Lijun J Sun
Journal:  Mol Cell       Date:  2009-02-13       Impact factor: 17.970

2.  Signaling pathway via TNF-alpha/NF-kappaB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis.

Authors:  Michio Onizawa; Takashi Nagaishi; Takanori Kanai; Ken-ichi Nagano; Shigeru Oshima; Yasuhiro Nemoto; Atsushi Yoshioka; Teruji Totsuka; Ryuichi Okamoto; Tetsuya Nakamura; Naoya Sakamoto; Kiichiro Tsuchiya; Kazuhiro Aoki; Keiichi Ohya; Hideo Yagita; Mamoru Watanabe
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-29       Impact factor: 4.052

3.  Encoding NF-kappaB temporal control in response to TNF: distinct roles for the negative regulators IkappaBalpha and A20.

Authors:  Shannon L Werner; Jeffrey D Kearns; Victoria Zadorozhnaya; Candace Lynch; Ellen O'Dea; Mark P Boldin; Averil Ma; David Baltimore; Alexander Hoffmann
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

4.  Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.

Authors:  Su-Chang Lin; Jee Y Chung; Betty Lamothe; Kanagalaghatta Rajashankar; Miao Lu; Yu-Chih Lo; Amy Y Lam; Bryant G Darnay; Hao Wu
Journal:  J Mol Biol       Date:  2007-12-04       Impact factor: 5.469

5.  Linkage-specific avidity defines the lysine 63-linked polyubiquitin-binding preference of rap80.

Authors:  Joshua J Sims; Robert E Cohen
Journal:  Mol Cell       Date:  2009-03-27       Impact factor: 17.970

6.  Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus.

Authors:  Stacy L Musone; Kimberly E Taylor; Timothy T Lu; Joanne Nititham; Ricardo C Ferreira; Ward Ortmann; Nataliya Shifrin; Michelle A Petri; M Ilyas Kamboh; Susan Manzi; Michael F Seldin; Peter K Gregersen; Timothy W Behrens; Averil Ma; Pui-Yan Kwok; Lindsey A Criswell
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

7.  Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus.

Authors:  Robert R Graham; Chris Cotsapas; Leela Davies; Rachel Hackett; Christopher J Lessard; Joanlise M Leon; Noel P Burtt; Candace Guiducci; Melissa Parkin; Casey Gates; Robert M Plenge; Timothy W Behrens; Joan E Wither; John D Rioux; Paul R Fortin; Deborah Cunninghame Graham; Andrew K Wong; Timothy J Vyse; Mark J Daly; David Altshuler; Kathy L Moser; Patrick M Gaffney
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

8.  Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways.

Authors:  Rajan P Nair; Kristina Callis Duffin; Cynthia Helms; Jun Ding; Philip E Stuart; David Goldgar; Johann E Gudjonsson; Yun Li; Trilokraj Tejasvi; Bing-Jian Feng; Andreas Ruether; Stefan Schreiber; Michael Weichenthal; Dafna Gladman; Proton Rahman; Steven J Schrodi; Sampath Prahalad; Stephen L Guthery; Judith Fischer; Wilson Liao; Pui-Yan Kwok; Alan Menter; G Mark Lathrop; Carol A Wise; Ann B Begovich; John J Voorhees; James T Elder; Gerald G Krueger; Anne M Bowcock; Gonçalo R Abecasis
Journal:  Nat Genet       Date:  2009-01-25       Impact factor: 38.330

9.  ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development.

Authors:  Shigeru Oshima; Emre E Turer; Joseph A Callahan; Sophia Chai; Rommel Advincula; Julio Barrera; Nataliya Shifrin; Bettina Lee; T S Benedict Yen; Benjamin Yen; Tammy Woo; Barbara A Malynn; Averil Ma
Journal:  Nature       Date:  2008-12-07       Impact factor: 49.962

10.  Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20.

Authors:  Emre E Turer; Rita M Tavares; Erwan Mortier; Osamu Hitotsumatsu; Rommel Advincula; Bettina Lee; Nataliya Shifrin; Barbara A Malynn; Averil Ma
Journal:  J Exp Med       Date:  2008-02-11       Impact factor: 14.307

View more
  73 in total

1.  A Structural View of Negative Regulation of the Toll-like Receptor-Mediated Inflammatory Pathway.

Authors:  Emine Guven-Maiorov; Ozlem Keskin; Attila Gursoy; Ruth Nussinov
Journal:  Biophys J       Date:  2015-08-11       Impact factor: 4.033

2.  A20 suppresses vascular inflammation by recruiting proinflammatory signaling molecules to intracellular aggresomes.

Authors:  Karine Enesa; Herwig P Moll; Le Luong; Christiane Ferran; Paul C Evans
Journal:  FASEB J       Date:  2015-02-09       Impact factor: 5.191

Review 3.  Diverse ubiquitin linkages regulate RIP kinases-mediated inflammatory and cell death signaling.

Authors:  Axel Witt; Domagoj Vucic
Journal:  Cell Death Differ       Date:  2017-05-05       Impact factor: 15.828

4.  NF-κB and Rheumatoid Arthritis: Will Understanding Genetic Risk Lead to a Therapeutic Reward?

Authors:  Robert Scheinman
Journal:  For Immunopathol Dis Therap       Date:  2013-04-01

5.  A20: attractive without showing cleavage.

Authors:  Kelly Verhelst; Geert van Loo; Rudi Beyaert
Journal:  EMBO Rep       Date:  2014-05-30       Impact factor: 8.807

Review 6.  Ubiquitin-Modifying Enzymes and Regulation of the Inflammasome.

Authors:  Michael G Kattah; Barbara A Malynn; Averil Ma
Journal:  J Mol Biol       Date:  2017-10-13       Impact factor: 5.469

Review 7.  Limiting inflammation-the negative regulation of NF-κB and the NLRP3 inflammasome.

Authors:  Inna S Afonina; Zhenyu Zhong; Michael Karin; Rudi Beyaert
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

8.  Ubiquitin-Dependent Regulation of Treg Function and Plasticity.

Authors:  Yi Dong; Fan Pan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4-1BB).

Authors:  Arantza Azpilikueta; Elixabet Bolaños; Valerie Lang; Sara Labiano; Maria A Aznar; Iñaki Etxeberria; Alvaro Teijeira; Maria E Rodriguez-Ruiz; Jose L Perez-Gracia; Maria Jure-Kunkel; Juan M Zapata; Manuel S Rodriguez; Ignacio Melero
Journal:  Oncoimmunology       Date:  2017-09-21       Impact factor: 8.110

10.  The ubiquitin-specific protease USP8 is critical for the development and homeostasis of T cells.

Authors:  Almut Dufner; Agnes Kisser; Sandra Niendorf; Anja Basters; Sonja Reissig; Anne Schönle; Annette Aichem; Thorsten Kurz; Andreas Schlosser; Deborah Yablonski; Marcus Groettrup; Thorsten Buch; Ari Waisman; Wolfgang W Schamel; Marco Prinz; Klaus-Peter Knobeloch
Journal:  Nat Immunol       Date:  2015-07-27       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.